Recruiting

Diabetes Virtual Visit

Sponsor:

Whole Endo

Code:

NCT07054125

Conditions

Type 2 Diabetes Mellitus - Poor Control

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Education, lifestyle counseling, and peer support

Study Details

Brief summary:

This research study is investigating whether a diabetes virtual group visit program using a continuous glucose monitor (CGM) can help improve glucose levels and quality of life in individuals with uncontrolled type 2 diabetes. People in the study will join group visits virtually to discuss using CGM, understanding CGM, and other information about ways to bring blood sugars to your goal (nutrition, movement, reducing stress, and techniques to start a new habit).

Conditions

Type 2 Diabetes Mellitus - Poor Control

Study ID

NCT07054125

Start date

Aug 1, 2025

Status verified date

Jun, 2025

Completion date

Aug, 2028

Anticipated

Primary completion date

Aug, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Adults aged 18 years and older
  • Diagnosed with type 2 diabetes mellitus Hemoglobin A1c >8% Must have smartphone to connect with continuous glucose monitor

Exclusion Criteria:

  • Pregnancy Use of steroids Active cancer treatment Terminal illness Dementia, mental impairment Type 1 diabetes End stage renal disease, on dialysis

Study Design

Enrollment

100 participants

Anticipated

Interventions and Outcome Measures

Interventions

Education, lifestyle counseling, and peer support

This research study is investigating whether a diabetes virtual group visit program using a continuous glucose monitor (CGM) can help improve glucose levels and quality of life in individuals with uncontrolled type 2 diabetes.

People in the study will join group visits virtually to discuss using CGM, understanding CGM, and other information about ways to bring blood sugars to your goal (nutrition, movement, reducing stress, and techniques to start a new habit).

Primary outcome measure

  • Hemoglobin A1c [ Time Frame: 12 weeks ]

Central Contacts and Locations

Central contacts

Rashim Gupta, MD

980-349-6036rashim.gupta@wholeendo.com

Javier Samayoa, EdD

javier.samayoa@wholeendo.com

Locations

Whole Endo

Recruiting

Asheville, North Carolina, United States, 28801

More Information

Sponsor

Whole Endo

Last update posted

Jul 8, 2025

Last verified

Jun, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Whole Endo on 2025-07-08.